Get startedLog in
    Picture of Solara Active Pharma Sciences logo

    SOLARA — Solara Active Pharma Sciences Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Solara Active Pharma Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line1,1492,215-911-448-4,884
    Depreciation
    Non-Cash Items7596456867561,796
    Discontinued Operations
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-408-2,392-3,3191433,143
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities2,4421,555-2,4201,5631,089
    Capital Expenditures-2,689-1,745-2,086-1,113-411
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-899682-342302376
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-3,588-1,063-2,429-811-35.1
    Financing Cash Flow Items-838-832-734-875-1,026
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities9499253,336-1,128-1,057
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-1971,417-1,513-377-2.9